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INTRODUCTION 
Cefotaxime Sodium is parentral third generation 
cephalosporin 
1, 2
. Several investigations on 
Cefotaxime Sodium have indicated that it is an 
parentally active antibiotic with similar antibacterial 
spectrum and resistance to β-lactamase as for other 
parenteral third generation cephalosporins 
3, 4
. The 
injection of cefotaxime is useful in emergency cases and 
used BD in a day. Cefotaxime Sodium has potent 
antibacterial activity against a wide range of bacteria, 
highly stable towards β-lactamases and long duration 
of action 
3
. Memon et al. reported Cefotaxime Sodium 
as a safe, effective, and cheaper oral option for the 
treatment of multidrug-resistance 
5
. The chemical 
structure of Cefotaxime Sodium consists of the cefem 
nucleus that is bicyclic and formed with fusion of , a β-
lactam ring & 6-membered dihydrothiazine ring. The 
cephem nucleus incorporates two important groups: 
the vinyl group at the 3-position, which is responsible 
for the intestinal absorption of the intact molecule. 
Other groups are the aminothiazole ring and the acetic 
acid oxy-imine group on the side chain at the 7-
position, which are associated with the antibacterial 
activity
4
. So it was thought of interest to develop a 
simple, specific and sensitive RP-HPLC method for 
determination of Cefotaxime Sodium in Injection
5
. 
Chemical formula: 
C16H16N5NaO7S2 
A number of methods has been used for the analysis 
of Cefotaxime Sodium in  raw material, in 
pharmaceutical dosage forms as well as in biological 
fluids such as Rathinavel et al., who used RP-HPLC 
method for the estimation of Cefotaxime Sodium in 
tablets
6
, Meng et al., who used liquid chromatographic- 
tandem mass spectrometric method to determine 
Cefotaxime Sodium in human plasma7, also, Al-Momani 
used Spectrophotometric method for the determination of 
drug in formulations
8
, whereas Eric-Jovanovic et al. used 
HPTLC method for the determination of Cefotaxime 
Sodium in dosage forms
9
, and finally Liu et al., used 
HPLC method for the analysis of Cefotaxime Sodium 
in human plasma and urine10 
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ABSTRACT 
A simple, sensitive, fast & precise Reverse Phase High Performance Liquid Chromatographic method was developed for the 
determination of Cefotaxime Sodium in pharmaceutical dosage form. The RP-HPLC separation was achieved on hypersil C18 
column (250 mm, 4.6 mm, 5µm) using mobile phase consisting of  buffer solution (sodium dihydrogen phosphate) : acetonitrile  
[37: 63 v/v, pH=2.75 adjusted with phosphoric acid] at a flow rate of 1ml/min and the retention time was about 6 minutes. The 
method is selective to Cefotaxime Sodium and able to resolve the drug peak from formulation excipients. The system suitability with 
retention time was (Mean + %CV) 8.600 + 0.186.The calibration curve was linear over the concentration range of 1-20µg/ml (r2 = 
0.999). The proposed method is accurate and precise (Intra day and Inter day variation, RSD were 0.55-1.67) and linear within 
the desired range. The LOD and LOQ was detected as 0.0187µg/ml and 0.043µg/ml respectively with r2 = 0.9997. The 
accuracy result of seventy percent drug (80%) was 99.87%, hundred percent (100%) was 99.93%, and one thirty percent (120%) 
was 100.18%. Therefore, this method could be used as a more convenient and efficient option for the analysis of Cefotaxime Sodium 
in raw material and Parentral dosage form. 
Keywords:    Third    generation    cephalosporin;    Cefotaxime Sodium;    Method    validation;    HPLC    method 
determination; Quantitative analysis 
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MATERIALS AND METHODS 
All the reagents used were of HPLC grade and 
analytical grade. Reference standard of Cefotaxime 
Sodium was supplied as gift sample from Sun 
Pharmaceutical Laboratories Limited, Jammu with 
purity of 99.987% Injection of three different 
companies (TAXIMO-500 mg from  Alchem Pharma 
Ltd., BIOTAX-500 mg from Unichem Pharma Ltd. and 
CLAFORAN-200 mg from M/s MNC Pharma Ltd) 
were procured from the local pharmacy in the market. A 
standard stock solution of Cefotaxime Sodium (1 
mg/ml) was prepared by dissolving 25 mg of drug 
powder in 25 ml of acetonitrile
9-12
. Working standard 
solution (100 µm/ml) was prepared from stock solution 
by proper dilution with acetonitrile and water mixture. 
A Labtronic Model 3201 (LC -2010
TH
 –Liquid 
Chromatography) equipped with PDA detector. 
Promesil C18 ((250 mm, 4.6 mm, 5µm) column and LC 
software were used. The mobile phase used was 
Phosphate buffer : acetonitrile (37:63 v/v) which was 
filtered through nylon 0.45 µm membrane filter and 
degassed by ultrasonication for 10 min. 
RESULT AND DISCUSSION  
Linearity of the method was investigated by serially 
diluting the working standard to give a concentration 
range of 1-10 µm/ml and 20 µl from this was injected. 
The flow rate was maintained at 1 ml/min. temperature 
of column was kept ambient and the effluent was 
monitored at 254 nm. Calibration curve was constructed 
by plotting concentration against peak area. The method 
was validated for linearity, precision, accuracy, 
specificity, limit of detection and limit of quantification 
as per ICH guidelines.  
 
 
 
 
Figure 1: Standard Curve of Cefotaxime Sodium 
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Figure 2: Infra Red Spectrum of Cefotaxime Sodium 
 
Assay of Injection of Cefotaxime Sodium were 
perfomed. Ten Injection of each company of strength 
250 mg, 500 mg and 2 g were weighed and ground to a 
fine powder. A quantity of  powder equivalent to 10 mg 
of Cefotaxime Sodium was transferred to 10 ml 
volumetric flask, dissolved and diluted with acetonitrile 
and water mixture to obtain 1 mg/ml. The solution was 
sonicated for 15 minute and filtered through 0.45 µm 
membrane filter. The solution was further diluted to 
obtain concentration 10 µm/ml. Peak area of the above 
prepared solutions of Cefotaxime Sodium were 
measured by using above mentioned chromatographic 
conditions and the amount of Cefotaxime Sodium were 
found from regression equation. 
To optimize the HPLC parameters, several mobile 
phase compositions were tried. Various mobile phases 
having different ratios of methanol, water and 
acetonitrile were tried. Drug was retained in mobile 
phase consisting of Phosphate buffer : acetonitrile (40 : 
60 v/v) and methanol : acetonitrile (45 : 55 v/v). In 
methanol : water (60 : 40 v/v) tailing in the peak was 
observed. Good peak symmetry and satisfactory 
retention time was obtained with mobile phase 
consisting of Phosphate buffer : acetonitrile (37:63 v/v). 
Quantification was achieved with PDA detection at 277 
nm based on peak area. The retention time of 
Cefotaxime Sodium obtained was 6.60±0.132 (fig. 3). 
The system suitability tests for HPLC were carried out 
on freshly prepared solution of Cefotaxime Sodium (10 
µg/ml) and parameters were studied. The results were 
summarized in Table 1. 
 
 
Table 1: HPLC instrumentation & chromatographic conditions for Cefotaxime Sodium 
Parameters Description 
Instrument A HPLC instrument Labtronic  with Model 3201  
Column Hypersil C-18, (250 mm, 4.6 mm, 5µm) 
Mobile Phase Different mobile phase used for Trial 1 to 6 
Flow Rate 1.0 mL/minute 
Detection 
wavelength 
277 nm 
Injection Volume 10L 
Run Time 25 minutes 
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Figure 3: Overlay chromatogram of standard Cefotaxime Sodium (10 µg/ml) 
 
Table 2: System Suitability Test Parameters 
Parameters                                                                                 RP-HPLC method 
Retention time, min                                                                   8.600±0.186 
Tailing factor                                                                             1.034±0.328 
Asymmetry factor                                                                      1.142±0.358 
Theoretical plates                                                                       6753±0.648 
Resolution                                                                                  2.754±0.329  
 
The linear regression date showed a good linear 
relationship over the concentration range of 1-10 µg/ml 
as summarized in Table 3. The limit of detection (LOD) 
and the limit of quantification(LOQ) of the drug were 
found by scanning the solution of Cefotaxime Sodium 
having different lower concentrations and the LOD and 
LOQ were found to be 0.5 and 1 µg/ml indicates that 
method is sensitive (Table 3). The intraday and interday 
precision were determined by analyzing standard 
solution of Cefotaxime Sodium at three different 
concentration levels (6, 8, 10  µg/ml). The % RSD for 
intraday and interday precision was found to be 0.235 – 
0.752% and 0.534-1.070% respectively which indicate 
that method is precise (Table 3). Repeatability of the 
method was studied by injecting 10 µg/ml solution of 
Cefotaxime Sodium for six times and peak area was 
measured and % RSD was calculated which was found 
to be 0.189 shows repeatability of the method (Table 3). 
Accuracy of the method was evaluated by standard 
addition method in which appropriate portion of stock 
solutions of Cefotaxime Sodium were spiked into blank 
placebo matrix to produce concentrations of 80 100 and 
120% of theoretical concentration. The mean recovery 
of spiked samples obtained was in range of 99.87 to 
100.18 reveals no interference of excipients and shows 
that method is accurate. The proposed validated method 
was successfully applied to determine Cefotaxime 
Sodium in tablet form. The results obtained for tablets 
of Cefotaxime Sodium were comparable with the 
corresponding  labeled amounts (0.5 mg/tab) (table 3). 
Robustness of the method was estimated by changing 
the mobile phase composition (3±3), wavelength ±1 
nm, injection  volume (20±2µl), column temperature 
(40±3
0
) and RSD values for all these changes calculated 
were less than 2 indicate that proposed method is 
robust. The proposed RP-HPLC method was accurate, 
precise, sensitive and rapid. The method also can be 
extended for the routine analysis of Cefotaxime Sodium 
in tablet dosage form. 
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Table 3: Regression characteristics and Validation Parameters 
Sr. No. Parameter Value 
1. λmax (nm) 254 
2. Linearity range 1– 20 
3. Correlation coefficient (r
2
) 0.999 
4. Regression equation Y=0.66X +0.003 
5. Intercept (a) .0026 
6. Slope (b) 0.9967 
7. Limit of detection (LOD μg/ml) 0.325 
8. Limit of quantification(LOQ μg/ml) 0.956 
9. Accuracy (%) 99.87-100.18 
10. Repeatability (RSD, %, n=6) 0.189
 
11. Precision (RSD %), Interday (n=3) 0.534-1.070% 
12. Intraday (n=3) 0.235-0.752 
 
Table 4: Results of analysis of commercial Dosage form of Cefotaxime Sodium 
Tablet  
Formulation 
Label 
claim(
mg) 
Drug 
added 
(mg) 
% Label claim 
estimated*(Mean ± 
S.D.) 
% Coeff. of 
variation 
Standard 
error 
I(TAXIMO) 250 100 99.876 ± 1.446 1.325 0.853 
II(BIOTAX) 500 300 99.934 ± 1.278 1.268 0.624 
III (CLAFORAN) 2000 1000 100.183 ±0.785 0.683 0.513 
*Average of six determinations 
 
CONCLUSION  
It is thus concluded that the proposed method is new, 
simple, cost effective, accurate, safe, free from pollution 
and precise and can be successfully employed in the 
routine analysis of this drug in pharmaceutical tablet 
dosage forms. The proposed method shall prove equally 
effective to analyze Cefotaxime Sodium in the 
corresponding drug sample and may prove to be of 
great importance in pharmaceutical analysis. 
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